# The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Influenza (Acute Upper Respiratory Infection)

> **NCT02622659** · PHASE4 · COMPLETED · sponsor: **Guangzhou Yipinhong Pharmaceutical CO.,LTD** · enrollment: 468 (actual)

## Conditions studied

- Acute Upper Respiratory Infection

## Interventions

- **DRUG:** Fuganlin Oral Liquid
- **DRUG:** Xiaoer Jiebiao Oral Liquid

## Key facts

- **NCT ID:** NCT02622659
- **Lead sponsor:** Guangzhou Yipinhong Pharmaceutical CO.,LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 468 (ACTUAL)
- **Last updated:** 2017-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02622659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02622659, "The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Influenza (Acute Upper Respiratory Infection)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02622659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*